Topic Archives: Actavis (ACT)

Special Bulletin: The CoLucid IPO

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He chooses his own topics, and his words and opinions are his own. You can see all of his articles archived here. Enjoy!] CoLucid Pharmaceuticals, which recently moved from Durham, NC, to Cambridge, MA, plans an initial public offering. Recent news suggests the […]

Saving Jack Kerouac

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his words and opinions are his own. Enjoy!] His tidily rhyming names perhaps destined him for fame. While Jack Kerouac’s work and popularity were before my time, his cultural and literary restlessness assure him […]

Comments

  • Avatar

    Steve take a look at Travis Real Money Portfolio. The spreadsheet has 3 of those stocks with stop loss triggers from Tra...

  • Avatar

    $FYI - PV-Tech Newsletter: US Edition - 4/11/2019 Some of todays articles; China to back-up Jinko and LONGi in...

  • Travis Johnson, Stock Gumshoe
  • Travis Johnson, Stock Gumshoe

    It is not necessarily profitable to predict recessions, and it is also almost impossible to do so with any degree of acc...

  • Avatar

    What I am not sure on is do they pay 11% per month on Rent Checks From the Government REIT's or is it accrued for the ye...

  • LongOnLife

    Any "cure" for any potentially fatal disease would be a tremendous blockbuster for the company that develops it. It is t...

  • Avatar

    I laughed out loud too. I love how Travis’s tears these newsletters apart. But I’m not sure which is worse - inve...

  • Avatar

    Fire Arm Daily Please find below a message from our advertising sponsor. Our email newsletter is a free service to you ...

  • Travis Johnson, Stock Gumshoe

    Weather forecasters have made amazing progress using "big data," probably much more than most investment forecasters -- ...

  • Avatar

    Speaking of "security", how secure are our finances in light of: "New Law Gives Banks Ability to Seize Your Accounts"...

  • Avatar

    I've gotten the new pitch for the same thing with a "Act before Feb. 19th" pitch. Thanks for the info....

  • Avatar

    The situation has been created by 50 years of unlimited debt spending with the Congress being bought off and derelict in...

  • Avatar

    Gumshoe, you are AWESOME!!! I think people like Zachary Scheidt should be thrown in Jail for scamming innocent people. T...

  • Avatar

    William, I thank you kindly for your advice and hope to act early in Feb. Sonny...

  • Avatar

    James Altucher is not eccentric, unconventional or a kook. In my opinion, this is all an act. He thinks his acting will...

  • Avatar

    Many years ago,I subscribed to the Weiss Ultimate Portfolio. Their strategy of only buying stocks with the highest WEI...

  • Avatar

    Left identified INGN as his next short target, May 24 when it was at 170. It momentarily dropped to 157 but then went o...

  • Avatar

    Travis, Thanks for great honest writings and insights. Just a question: Instead of wait for your weekly update. Is it po...

  • Avatar

    Interesting, since I do like everything not of this planet. It will be interesting to see which occurs first...a drug c...

  • Avatar
  • Avatar
  • Avatar

    Yes where is my late checks of $2748.00?...

  • Avatar

    Writing is very good. Both Rickards and King graduated from big time law schools, they have been trained to write convi...

  • Avatar

    Just got a chance to listen to Trevena(TRVN)Jefferies presentation by Max Gowen(who is a great speaker and leading this ...

  • Avatar

    Nice article on Actavis (ACT). http://www.ft.com/intl/cms/s/0/472bfe98-d279-11e4-ae91-00144feab7de.html?ftcamp=crm/emai...

  • Avatar

    Actavis (ACT) price target raised to 373.00 by BMO Capital. http://www.americanbankingnews.com/2015/03/18/actavis-plc-p...

  • Dr. KSS, MD PhD

    Actavis $ACT to issue $20B in corporate bonds. Not sure what big deal Brent Saunders is mulling next, but it is likely t...

  • Dr. KSS, MD PhD

    I went long on Irish roll-up Actavis $ACT last year as a speculation on it being a lovely tax inversion play for a US ma...

  • Avatar

    Actavis (ACT) swallowing companies left and right. http://www.ddn-news.com/index.php?newsarticle=9210 Cheers,Glenn...

  • Dr. KSS, MD PhD

    Hi all: My respect goes out to the retired and active service military members here, for doing something I would not ...

  • Dr. KSS, MD PhD

    A couple of updates: GILD shares are sagging in part on concern that ABBV, whose HCV regimen is up for FDA approval ...

  • Avatar

    YES!!!! Durata Therapeutics to be acquired by Actavis (ACT) for $23.00/share in cash, or ~$675 million in the aggregate...

  • Dr. KSS, MD PhD

    $PFE to do tax inversion takeover of Actavis $ACT? Would be quite good fit, I feel....

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch